http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0211526-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-59 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 |
| filingDate | 1986-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2e57aca16562081f0b08922ade4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6f45246bff5b44e6f23502431421131 |
| publicationDate | 1987-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0211526-A2 |
| titleOfInvention | Cephalosporins, their preparation and formulations |
| abstract | 7p-Heterocyclicacetylamino-(and 7β-heterocyclic- thioacetamido)-3-chloro-3-cephem-4-carboxylic acids or pharmaceutically acceptable salts thereof (e.g., 7β-[2-(2-aminothiazol-4-yl)acetamido]-3-chloro-3-cephem-4-carboxylic acid and salts thereof) exhibit surprising peroral bioavailability and are useful for treating infections in a warm-blooded animal. The have the formulain which R is a 5-membered nitrogen-containing heterocyclic ring of the formulaeorY is S or a bond;in which in the above formulae Z is O, S, or N and R' is hydrogen, hydroxy, halo, amino, C<sub>1</sub>-C<sub>4</sub> alkanoylamino, C<sub>1</sub>-C<sub>4</sub> alkylamino, di-(C<sub>1</sub>-C<sub>4</sub> alkyllamino, C<sub>1</sub>-C<sub>4</sub> alkylsulfonylamino, C<sub>1</sub>-C<sub>4</sub> alkanoyloxy, C<sub>1</sub>-C<sub>4</sub> alkoxy, C<sub>1</sub>-C<sub>4</sub> alkylsulfonyloxy, C<sub>1</sub>-C<sub>4</sub> alkyl, phenyl, or trihalomethyl;R<sub>1</sub> is hydrogen, methoxy, or formamido; or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4950660-A |
| priorityDate | 1985-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 577.